158 related articles for article (PubMed ID: 9570543)
1. An intronic silencer regulates B lymphocyte cell- and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene.
Makar KW; Pham CT; Dehoff MH; O'Connor SM; Jacobi SM; Holers VM
J Immunol; 1998 Feb; 160(3):1268-78. PubMed ID: 9570543
[TBL] [Abstract][Full Text] [Related]
2. Cell- and stage-specific chromatin structure across the Complement receptor 2 (CR2/CD21) promoter coincide with CBF1 and C/EBP-beta binding in B cells.
Cruickshank MN; Fenwick E; Karimi M; Abraham LJ; Ulgiati D
Mol Immunol; 2009 Aug; 46(13):2613-22. PubMed ID: 19487031
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the human complement receptor 2 (CR2, CD21) promoter reveals sequences shared with regulatory regions of other developmentally restricted B cell proteins.
Rayhel EJ; Dehoff MH; Holers VM
J Immunol; 1991 Mar; 146(6):2021-6. PubMed ID: 1706386
[TBL] [Abstract][Full Text] [Related]
4. Cell-specific expression of the murine CD21 gene depends on accessibility of promoter and intronic elements.
Zabel MD; Byrne BL; Weis JJ; Weis JH
J Immunol; 2000 Oct; 165(8):4437-45. PubMed ID: 11035082
[TBL] [Abstract][Full Text] [Related]
5. Expression of the murine CD21 gene is regulated by promoter and intronic sequences.
Hu H; Martin BK; Weis JJ; Weis JH
J Immunol; 1997 May; 158(10):4758-68. PubMed ID: 9144490
[TBL] [Abstract][Full Text] [Related]
6. A highly conserved c-fms gene intronic element controls macrophage-specific and regulated expression.
Himes SR; Tagoh H; Goonetilleke N; Sasmono T; Oceandy D; Clark R; Bonifer C; Hume DA
J Leukoc Biol; 2001 Nov; 70(5):812-20. PubMed ID: 11698502
[TBL] [Abstract][Full Text] [Related]
7. Identification of 5'-regions affecting the expression of the human CR2 gene.
Yang LM; Behrens M; Weis JJ
J Immunol; 1991 Oct; 147(7):2404-10. PubMed ID: 1833454
[TBL] [Abstract][Full Text] [Related]
8. Yin Yang 1, Oct1, and NFAT-4 form repeating, cyclosporin-sensitive regulatory modules within the murine CD21 intronic control region.
Zabel MD; Wheeler W; Weis JJ; Weis JH
J Immunol; 2002 Apr; 168(7):3341-50. PubMed ID: 11907091
[TBL] [Abstract][Full Text] [Related]
9. Identification of sites for distinct DNA binding proteins including Oct-1 and Oct-2 in the Cr2 gene.
Christensen SM; Martin BK; Tan SS; Weis JH
J Immunol; 1992 Jun; 148(11):3610-7. PubMed ID: 1534100
[TBL] [Abstract][Full Text] [Related]
10. [Human immunoglobulin heavy-chain gene intronic enhancer segment HE2 (microB) functions as a major B-cell specific cis-element at cellular level as well as in transgenic mice].
Enjoji M
Fukuoka Igaku Zasshi; 1992 Jun; 83(6):262-74. PubMed ID: 1511952
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of the complement receptor 2 gene: role of a heterogeneous nuclear ribonucleoprotein.
Tolnay M; Lambris JD; Tsokos GC
J Immunol; 1997 Dec; 159(11):5492-501. PubMed ID: 9548489
[TBL] [Abstract][Full Text] [Related]
12. A 150-base pair 5' region of the MHC class I HLA-B7 gene is sufficient to direct tissue-specific expression and locus control region activity: the alpha site determines efficient expression and in vivo occupancy at multiple cis-active sites throughout this region.
Kushida MM; Dey A; Zhang XL; Campbell J; Heeney M; Carlyle J; Ganguly S; Ozato K; Vasavada H; Chamberlain JW
J Immunol; 1997 Nov; 159(10):4913-29. PubMed ID: 9366417
[TBL] [Abstract][Full Text] [Related]
13. Differentiation-specific transcriptional regulation of the ESE-2 gene by a novel keratinocyte-restricted factor.
Tummala R; Sinha S
J Cell Biochem; 2006 Mar; 97(4):766-81. PubMed ID: 16229011
[TBL] [Abstract][Full Text] [Related]
14. Intrinsic B cell hypo-responsiveness in mice prematurely expressing human CR2/CD21 during B cell development.
Kulik L; Marchbank KJ; Lyubchenko T; Kuhn KA; Liubchenko GA; Haluszczak C; Gipson MG; Boackle SA; Holers VM
Eur J Immunol; 2007 Mar; 37(3):623-33. PubMed ID: 17301948
[TBL] [Abstract][Full Text] [Related]
15. Functional dissection of the murine lck distal promoter.
Wildin RS; Wang HU; Forbush KA; Perlmutter RM
J Immunol; 1995 Aug; 155(3):1286-95. PubMed ID: 7636195
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
17. A site in the complement receptor 2 (CR2/CD21) silencer is necessary for lineage specific transcriptional regulation.
Makar KW; Ulgiati D; Hagman J; Holers VM
Int Immunol; 2001 May; 13(5):657-64. PubMed ID: 11312253
[TBL] [Abstract][Full Text] [Related]
18. Distinct stage-specific cis-active transcriptional mechanisms control expression of T cell coreceptor CD8 alpha at double- and single-positive stages of thymic development.
Zhang XL; Seong R; Piracha R; Larijani M; Heeney M; Parnes JR; Chamberlain JW
J Immunol; 1998 Sep; 161(5):2254-66. PubMed ID: 9725219
[TBL] [Abstract][Full Text] [Related]
19. The 14.1 surrogate light chain promoter has lineage- and stage-restricted activity.
Donohoe ME; Blomberg BB
J Immunol; 1997 Feb; 158(4):1681-91. PubMed ID: 9029104
[TBL] [Abstract][Full Text] [Related]
20. Cloning and molecular dissection of the 8.8 kb pig uroplakin II promoter using transgenic mice and RT4 cells.
Kwon DN; Choi YJ; Park JY; Cho SK; Kim MO; Lee HT; Kim JH
J Cell Biochem; 2006 Oct; 99(2):462-77. PubMed ID: 16619260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
